Augmented reality company Medivis is highlighting its $20 million series A funding round led by researchers, investors, and NBA superstar Kevin Durant.
Along with Durant, the funding round was led by Thrive Capital with participation from Initialized Capital and Mayo Clinic. Additional investors include Bob Iger; Robert Spetzler, MD; Hugo Barra; and Coalition Operators.
Medivis said money received from the fundraising round will be used to scale engineering, obtain regulatory clearances, and commercialize its offerings across multiple specialties. These include neurosurgery, orthopedic surgery, interventional radiology, and reconstructive surgery.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
